ReviewPharmaceutics2021
Formulation Considerations for Autologous T Cell Drug Products.
Christopher F van der Walle et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewPharmaceutics2021
Christopher F van der Walle et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.